# Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Source: https://onco.cc/trials/nct05620017/  
OnCo record `nct05620017` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.

## Summary

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection. ClinicalTrials.gov record last updated 2026-02-09: recruiting. Enrollment is planned at 182 participants. Primary completion is estimated at 2027-05-31. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Registry id: NCT05620017
- Phase: 1
- Setting: Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
- Sponsor: Bio-Thera Solutions

## Notes

- ClinicalTrials.gov record last updated 2026-02-09: recruiting. Enrollment is planned at 182 participants. Primary completion is estimated at 2027-05-31. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT05620017: https://clinicaltrials.gov/study/NCT05620017

## Connected records

- targets: [TROP2](https://onco.cc/targets/trop2/)
- drugs: [BAT8008](https://onco.cc/drugs/bat8008/)

---
JSON: https://onco.cc/api/v1/entities/nct05620017.json